Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Healthy ageing phenotypes and trajectories 

Healthy ageing phenotypes and trajectories
Chapter:
Healthy ageing phenotypes and trajectories
Author(s):

Sebastiano Collino

, Blandine Comte

, Estelle Pujos Guillot

, Claudio Franceschi

, Antonio Nuñez Galindo

, Loïc Dayon

, and Martin Kussmann

DOI:
10.1093/med/9780198701590.003.0161
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 29 October 2020

The concept of healthy ageing today is linked to the efforts of maintaining physical and mental independence, and to prevent the decline of physiological functions that are mandatory to guarantee a good quality of life. Yet, an individual’s ageing trajectory and underlying mechanisms are multifaceted and still far from understood. Hence, there is an urgent need for the further development of ageing phenotypes that can be utilized in the identification of biomarkers to characterize and predict biological age, taking into account the multiple dimensions of ageing. New technologies, often termed ‘systems biology’ approaches, are being increasingly applied to research focused on ageing populations. These technologies should enable investigators, and eventually clinicians, to (a) understand ageing metabolism in a more detailed and specific way; (b) enable the phenotypic characterization of many age-related disorders including chronic disease states; and (c) stratify older adults and the multiple comorbid conditions that may impact them.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.